insights_auto
Why is TMCI down 11.57%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
US$4.66
arrow_downward
-11.57%(-0.61) 1D
ኖቬም 16, 10:55:54 ጥዋት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
US$5.23
High
US$5.36
Low
US$4.43
Mkt. cap
305.51 ሚ
Avg. vol.
298.58 ሺ
Volume
110.70 ሺ
52-wk high
US$5.44
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
Open
US$5.23
High
US$5.36
Low
US$4.43
Mkt. cap
305.51 ሚ
Avg. vol.
298.58 ሺ
Volume
110.70 ሺ
52-wk high
US$5.44
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
News stories
From web sources and news partners
MarketWatch
·
ከ16 ደቂቃዎች በፊት
These 13 S&P 500 stocks can rise up to 70% over the next year, according to analysts
Coinpaper
·
ከ59 ደቂቃዎች በፊት
Stock Market Today: S&P 500 and Nasdaq Fall as Nvidia Selloff Deepens
Traders Union
·
ከ28 ደቂቃዎች በፊት
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc